Ataxia Telangiectasia Children's
Data sourced from IRS 990 public filings
Ataxia Telangiectasia Children's Organizing and supporting innovative research, conferences, clinical teams, data platforms and biomarker development to optimize disease management strategies, develop new treatments, and find a cure for A-T, a genetic disease that causes loss of muscle control, cancer, lung disease, and immune system problems.
Ataxia Telangiectasia Children's has received 55 grants from 28 known foundation funders. Revenue decreased from $2,502,362 in 2023 to $1,808,873 in 2024. Most recent reported revenue: $1,808,873.
Annual Revenue
$1,808,873
Known Funders
28
Grants Received
55
Financial History
| Year | Revenue | Expenses | Assets |
|---|---|---|---|
| 2024 | $1,808,873 | $2,217,433 | $3,075,666 |
| 2023 | $2,502,362 | $1,895,973 | $2,802,981 |
| 2022 | $1,567,615 | $1,481,299 | $2,125,334 |
| 2021 | $1,739,187 | $1,713,346 | $2,011,038 |
| 2020 | $1,461,138 | $1,326,098 | $1,453,834 |
Top Funders
FT LAUDERDALE, FL
FT LAUDERDALE, FL
FT LAUDERDALE, FL
FT LAUDERDALE, FL
SOUTHEASTERN, PA
ROSELAND, NJ
WELLINGTON, FL
IRVINE, CA
IRVINE, CA
LAS VEGAS, NV
Showing top 10 of 28 funders.
Key Personnel
From 2024 IRS 990 filing
Bradley A Margus
President
Amy Madison
Vice President
Gregory Jehlik
Secretary
Timothy Rahall
Treasurer
Jennifer Thornton
Executive Director/Director
John Feeley
Director
Elizabeth Hughes
Director
Robert Middlebrook
Director
David Veldink
Director
Douglas Weckstein
Director
Frequently Asked Questions
Other Nonprofits in Florida
Unlock Full Nonprofit Data
Sign up for free to access the complete funder list, financial history, program details, key personnel, and smart matching.